Li-Fraumeni syndrome (LFS), first described in 1969, is an autosomal dominant cancer predisposition syndrome in pediatric cases and in young adults, which results from germline mutations in the TP53 tumor suppressor gene [13]. This evidence concerns the gene TP53 and Li-Fraumeni syndrome.